Reply to G Taubes, MI Friedman, and V Torres-Carot et al.

Authors

Kevin D. Hall, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
I. Sadaf Farooqi, University of Cambridge
Jeffery M. Friedman, Rockefeller University
Samuel Klein, Washington University School of Medicine in St. Louis
Ruth J.F. Loos, Novo Nordisk Foundation Center for Basic Metabolic Research
David J. Mangelsdorf, UT Southwestern Medical Center
Stephen O’Rahilly, University of Cambridge
Eric Ravussin, Pennington Biomedical Research Center
Leanne M. Redman, Pennington Biomedical Research Center
Donna H. Ryan, Pennington Biomedical Research Center
John R. Speakman, Shenzhen Institute of Advanced Technology
Deirdre K. Tobias, Harvard Medical School

Document Type

Letter to the Editor

Publication Date

8-1-2022

Recommended Citation

Hall, K., Farooqi, I., Friedman, J., Klein, S., Loos, R., Mangelsdorf, D., O’Rahilly, S., Ravussin, E., Redman, L., Ryan, D., Speakman, J., & Tobias, D. (2022). Reply to G Taubes, MI Friedman, and V Torres-Carot et al.. Retrieved from https://repository.lsu.edu/clinical_research_pubs/166